Director Paul J. Diaz submitted an initial statement of beneficial ownership of securities in Merck & Co., Inc. (NYSE:MRK), filed on November 3, 2026, reflecting holdings as of a triggering event dated November 1, 2026.

Key Highlights

  • Reporting person: Paul J. Diaz, identified as a Director of Merck & Co., Inc.
  • Triggering event date: November 1, 2026, per the filing.
  • Direct holdings: 200 shares of Merck Common Stock held directly by Diaz.
  • Indirect holdings: 96 shares of Merck Common Stock held indirectly through the reporting person's revocable trust.
  • No derivative securities: Table II of the filing lists no derivative securities beneficially owned.
  • Filing agent: The form was signed by Kelly Grez as attorney-in-fact for Paul J. Diaz, with reference to Exhibit 24, a Power of Attorney.

Paul J. Diaz Reports Initial Beneficial Ownership as Merck Director

According to the filing, Paul J. Diaz submitted a Form 3, Initial Statement of Beneficial Ownership of Securities, in connection with his role as a Director at Merck & Co., Inc. (NYSE:MRK). The date of the event requiring the statement is listed as November 1, 2026, and the form was filed on November 3, 2026. The filing was made by one reporting person and covers Diaz's beneficial ownership at the time of the triggering event.

The filing discloses two categories of Common Stock ownership. Diaz directly holds 200 shares of Merck Common Stock, according to Table I of the filing. An additional 96 shares are reported as indirectly held through what the filing describes as "Reporting Person's Revocable Trust." No derivative securities, such as options, warrants, or convertible instruments, are reported in Table II.

The filing notes that it was signed by Kelly Grez as attorney-in-fact for Paul J. Diaz on November 3, 2026, with the filing referencing Exhibit 24, a Power of Attorney. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934. No amendments to a prior Form 3 are indicated, confirming this is an initial filing.

What Was Disclosed

Paul J. Diaz disclosed an initial beneficial ownership position in Merck & Co., Inc. comprising 200 shares held directly and 96 shares held indirectly via a revocable trust, with no derivative securities reported, as of November 1, 2026.